Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology
Authors:
- 1 March 2021
- journal article
- review article
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 13 (1) , 25-35
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- The resolution of inflammationNature Reviews Immunology, 2012
- Eplerenone and Atrial Fibrillation in Mild Systolic Heart FailureJACC, 2012
- Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial FibrillationThe American Journal of Cardiology, 2011
- Left atrial reservoir function predicts atrial fibrillation recurrence after catheter ablation: a two-dimensional speckle strain studyJournal of Interventional Cardiac Electrophysiology, 2011
- Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary preventionEP Europace, 2011
- Interleukin-18 among atrial fibrillation patients in the absence of structural heart diseaseEP Europace, 2010
- Myeloperoxidase acts as a profibrotic mediator of atrial fibrillationNature Medicine, 2010
- Intracardiac and extracardiac markers of inflammation during atrial fibrillationHeart Rhythm, 2010
- Increased Inflammatory Cell Infiltration in the Atrial Myocardium of Patients With Atrial FibrillationThe American Journal of Cardiology, 2008
- Human Epicardial Adipose Tissue Is a Source of Inflammatory MediatorsCirculation, 2003